CRESCENT BIOPHARMA, INC. Money Market Funds, at Carrying Value
CRESCENT BIOPHARMA, INC. (CBIO) had Money Market Funds, at Carrying Value of $207.90 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2019-03-06
- 2018-12-31: Money Market Funds, at Carrying Value $207.90M.
- 2017-12-31: Money Market Funds, at Carrying Value $121.90M.
- 2016-12-31: Money Market Funds, at Carrying Value $38.00M.
- 2016-06-30: Money Market Funds, at Carrying Value $50.10M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2018-12-31 | $207.90M 10-K · filed 2019-03-06 |
| 2017-12-31 | $121.90M 10-K · filed 2019-03-06 |
| 2016-12-31 | $38.00M 10-K · filed 2018-03-06 |
| 2016-06-30 | $50.10M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $36.50M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $45.50M 10-K · filed 2017-03-01 |
| 2015-09-30 | $52.50M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $39.50M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $45.50M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $55.00M 10-K · filed 2016-02-29 |
| 2014-09-30 | $61.00M 10-Q · filed 2014-10-31 |
| 2014-06-30 | $64.10M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $56.70M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $2.20M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |